Quality agreements between product owners and contract facilities do a specific job: they allocate CGMP responsibilities so both parties know who manufactures, who tests, who releases, who investigates and who notifies whom. Regulators expect that allocation to be documented, and reviewers expect it to be consistent with what actually happens on the floor. The document is the control; the behavior is the evidence, and a gap between the two is what findings are made of.
The document usually gets built carefully. What follows is less consistent. The responsibility matrix is a table in a PDF; the obligations inside it are ongoing duties with deadlines. Nothing in the document itself produces a reminder when a deviation notification window opens or an annual audit right lapses unused. The gap is not one of intent. It is that the commitments were never given owners, dates and a place to show evidence.
This datasheet sets out how Aavenir turns signed quality agreements into a live obligation register: what gets extracted, who owns each item, how evidence is attached, and what the quality organization sees when something slips. It is written for quality assurance, external manufacturing and supply chain teams managing a network of contract facilities, where the same responsibility pattern repeats across sites with enough variation to make manual tracking unreliable.
What gets extracted from a quality agreement
Extraction targets the operative commitments rather than the whole document. Most quality agreements contain a small number of clauses that generate recurring duties, and a larger body of definitional text that does not. Separating the two keeps the register short enough to be maintained and specific enough to be useful during an inspection, when the question is always whether a stated commitment was met on time.
- Responsibility matrix items, each row where one party is accountable for an activity, converted into an owned obligation with a review cadence.
- Notification windows, deviation, out-of-specification, change and recall notification periods, expressed as clock-driven obligations from the triggering event.
- Change control commitments, the categories of change requiring prior written approval, and the approval path and timing attached to each.
- Audit and inspection rights, routine audit frequency, for-cause rights, notice periods, and the duty to inform the other party of a regulatory inspection.
- Records and retention, batch record access, retention periods, sample retention duties and the return or destruction mechanism at termination.
The result is a register the quality organization can work from rather than a document it has to reread. Each item carries an owner, a due date or a cadence, an evidence slot and an escalation path. For the wider post-signature picture across regulated commitments, obligation management for life sciences covers the same engine applied to the full agreement portfolio.
Deviation and change notification obligations are time-bound, bilateral and easy to evidence, which makes them a natural place for a reviewer to test whether the quality agreement is operating rather than filed. Tracking the clock from the triggering event, and holding the notification artifact against the obligation, answers that line of questioning directly.
What the platform does
Aavenir treats the quality agreement as a source of structured commitments rather than an attachment. The agreement is stored with its amendments and linked to the commercial supply agreement, extraction proposes the obligation set for quality review, and confirmed obligations run on the same engine used for regulatory and commercial commitments elsewhere in the portfolio.
- Linked agreement pairs. The quality agreement and the supply agreement are held as linked records so a change to one surfaces against the other.
- Confidence-scored extraction. Proposed obligations are routed for quality approval before they go live, so the register reflects a reviewed position.
- Event-triggered clocks. Notification obligations start from a logged event, such as a deviation, rather than from a fixed calendar date.
- Evidence capture. Each obligation holds the artifact that proves performance, so closure is defensible months later.
- Escalation by severity. Missed critical notifications escalate on a different path from routine cadence items, with an auditable trail.
A five-step rollout for quality agreement tracking
Step 1, Inventory the agreement pairs
List every contract facility and confirm which quality agreement is current, which supply agreement it pairs with, and whether amendments are complete. Missing or superseded pairs are common in networks that have grown through acquisition, and they are simpler to fix before extraction than after.
Step 2, Standardize the responsibility matrix
Agree a common structure for the matrix across the network so activities, parties and cadences are expressed consistently. Standardization is what makes cross-site reporting possible; without it, each agreement produces obligations that cannot be compared or aggregated.
Step 3, Extract and review obligations
Run extraction across the current agreements, then have quality assurance confirm each proposed obligation, its owner and its cadence. Review is the step that makes the register trustworthy, and it is faster than building the register by hand from scratch.
Step 4, Wire the event triggers
Connect deviation, change and complaint events to the notification obligations they start. This turns a written window into a running clock with a visible due time, which is the difference between an obligation that is documented and one that is managed.
Step 5, Report and rehearse
Publish a network view of open, met and missed obligations by facility, and rehearse the inspection question: show the commitment, the owner, the evidence and the date. If that sequence takes more than a few minutes, the register needs work before an inspector asks.
Managing quality agreements across a CDMO network?
See how Aavenir converts responsibility matrices into monitored obligations with evidence attached.
How it fits the rest of the quality system
Obligation tracking does not replace the quality management system. Deviations, change controls and complaints continue to be managed where they are managed today. What the contract layer adds is the commitment view: which duties the agreement created, who holds them, when they fall due, and whether the evidence exists. The two connect through events, so a deviation logged in the quality system starts the notification clock that the agreement defined, and the closure artifact from the same process satisfies the obligation. Contract terms and operational reality stay aligned because they are driven by the same trigger rather than reconciled after the fact.
Coverage at a glance
The table summarizes what the module tracks for a typical contract manufacturing relationship, the trigger type behind each item and the evidence that closes it. Coverage is configured per agreement, so a testing laboratory relationship carries a different profile from a sterile fill and finish site. Owners are named roles rather than individuals, which keeps the register intact through staff changes and site transfers.
| Obligation type | Typical trigger | Owner | Closing evidence |
|---|---|---|---|
| Deviation notification | Deviation logged at the contract facility | Contract facility quality | Notification record with timestamp |
| Change notification and approval | Proposed change to process or materials | Contract facility quality | Written approval or rejection |
| Batch record review and release | Batch disposition | Product owner quality | Reviewed record and release decision |
| Routine audit | Annual or agreed cadence | Product owner external quality | Audit report and closure of findings |
| Records retention confirmation | Retention period milestone | Contract facility | Retention or destruction certificate |
A quality agreement that sits in a repository documents an intention. A quality agreement converted into owned, dated and evidenced obligations documents a system. The difference is visible in how quickly a team answers a reviewer question about notification timeliness, and in how rarely an audit right goes unused because nobody was reminded it existed. Neither outcome requires more quality headcount, only a register that carries the commitments forward. For the audit-evidence view across GxP records and electronic signatures, see 21 CFR Part 11 and GxP audit expectations.
For related guidance, see The quality leader’s guide to pharma quality agreements, The quality lead’s guide to CMO quality agreements and Quality agreement obligations, who tracks what in GxP.
